Skip to main content
. 2022 Jul 27;19:93. doi: 10.1186/s12966-022-01331-y

Fig. 2.

Fig. 2

Expected incremental reduction in 12-month obesity (A-B), cardiovascular disease cases (C-D) and new type 2 diabetes cases (EF), with different sensitivity analyses. A,C,E Results for the whole of London comparing basecase and all four sensitivity analysis scenarios. B) Results per 100,000 people of each IMD quintile with different sensitivity analyses. D,F Results per 100,000 people of each IMD quintile for sensitivity analysis SA1: no socioeconomic gradient in calorie reduction. SA2 no indirect metabolic effects; SA3 half calorie reduction; SA4 3 year duration of effect; SA5 1 year return to baseline BMI